Posted by Trevor Kearing on Jan 16th, 2026
Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have received an average recommendation of “Moderate Buy” from the fourteen analysts that are currently covering the company, Marketbeat Ratings reports....
More of this article »